An FDA draft guidance issued earlier this year on hospital glucose meters has attracted an unusual amount of attention, including criticism from clinicians, companies and others who worry it could cut off access to point-of-care glucose testing in patient cases where it is needed. The agency says it is taking appropriate measures to address a safety issue, and that some of the criticism is misdirected.
Excerpt from:
FDA Catches Heat For Plans To Raise Standards For Hospital Glucose Meters
Tags: fda, medical, medical devices, powered, qd syringe systems, qd-syringe, today, wordpress